NSB
EW icon

Norway Savings Bank’s Edwards Lifesciences EW Stock Holding History

Norway Savings Bank’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-120
Closed -$10K – 290
2022
Q3 		$10K Hold
120
– – 0.01% 247
2022
Q2 		$11K Hold
120
– – 0.01% 249
2022
Q1 		$14K Hold
120
– – 0.01% 249
2021
Q4 		$16K Sell
120
-20
-14% -$2.33K 0.01% 244
2021
Q3 		$16K Buy
140
+20
+17% +$2.28K 0.01% 248
2021
Q2 		$12K Hold
120
– – 0.01% 266
2021
Q1 		$10K Hold
120
– – 0.01% 271
2020
Q4 		$11K Hold
120
– – 0.01% 278
2020
Q3 		$10K Buy
+120
New +$9.36K 0.01% 259

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Norway Savings Bank's EW Position: Q4 2022 in Review

Norway Savings Bank sold out of Edwards Lifesciences (EW) in Q4 2022, closing a stake of 120 shares — an estimated $10K sold.

Norway Savings Bank first reported a position in EW in Q3 2020 and held it in 9 quarters. The position peaked at $16K in Q4 2021. 1,229 funds tracked by Wall St. Rank hold EW as of Q4 2022.

  • Norway Savings Bank reported no remaining Edwards Lifesciences position as of Q4 2022 after selling out during the quarter.
  • Norway Savings Bank sold 120 Edwards Lifesciences shares in Q4 2022, an estimated $10K.
  • Norway Savings Bank first reported a position in Edwards Lifesciences in Q3 2020 and held it in 9 quarters.
  • Norway Savings Bank's Edwards Lifesciences position peaked at $16K in Q4 2021.
  • 1,229 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2022.

Based on Norway Savings Bank's 13F filing for Q4 2022, filed 10 Jan 2023.